Literature DB >> 28580054

Percutaneous Cholecystostomy and Hydrodissection in Radiofrequency Ablation of Liver Subcapsular Leiomyosarcoma Metastasis Adjacent to the Gallbladder: Protective Effect.

André Azevedo1, Priscila Falsarella1, Rafael Rocha1, Antônio Rahal1, Rodrigo Garcia1.   

Abstract

Uterine leiomyosarcoma is an uncommon pathology, predominantly found in aged population. Patients with metastatic disease have poor survival and therapy mainly consists of palliative systemic chemotherapy. However, more aggressive strategies such as radiofrequency ablation (RFA) may benefit patients with limited secondary disease. RFA is considered a simple and safe modality for treatment of hepatic lesions. The benefits related to RFA include low morbidity, short hospital stay and the possibility to repeat the procedure when necessary due to recurrences. However, minor and major complications related to mechanical and thermal damage may occur, especially in cases of tumors adjacent to extrahepatic organs and those at subcapsular position. This case report shows a successful RFA of two hepatic subcapsular leiomyosarcoma metastases neighbouring the gallbladder, without a safe cleavage plane from it. Combined hydrodissection, percutaneous cholecystostomy and continuous irrigation were performed as effective techniques to prevent thermal injury. Clinical and radiological follow up demonstrates no local complication.

Entities:  

Keywords:  Cholecystostomy; Gallbladder; Hepatic metastasis; Hydrodissection; Leiomyosarcoma; Radiofrequency Ablation

Mesh:

Substances:

Year:  2016        PMID: 28580054      PMCID: PMC5443583          DOI: 10.3941/jrcr.v10i10.2677

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  14 in total

Review 1.  Radiofrequency ablation: technique and clinical applications.

Authors:  Servet Tatli; Umit Tapan; Paul R Morrison; Stuart G Silverman
Journal:  Diagn Interv Radiol       Date:  2012-03-09       Impact factor: 2.630

2.  Hydrodissection using an iodinated contrast medium during percutaneous renal cryoablation.

Authors:  Sutchin R Patel; J Louis Hinshaw; Meghan G Lubner; Meghan G Lubne; Fred T Lee; Stephen Y Nakada; Sean P Hedican
Journal:  J Endourol       Date:  2012-04-16       Impact factor: 2.942

3.  Gallbladder needle decompression during radiofrequency ablation of an adjacent liver tumour.

Authors:  Dellano D Fernandes; Paul B Shyn; Stuart G Silverman
Journal:  Can Assoc Radiol J       Date:  2012-01-27       Impact factor: 2.248

4.  Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.

Authors:  Wei Yang; Kun Yan; Gong-Xiong Wu; Wei Wu; Ying Fu; Jung-Chieh Lee; Zhong-Yi Zhang; Song Wang; Min-Hua Chen
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

5.  Ablation of liver tumors using percutaneous RF therapy.

Authors:  S N Goldberg; G S Gazelle; L Solbiati; T Livraghi; K K Tanabe; P F Hahn; P R Mueller
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

Review 6.  Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors.

Authors:  Alexandre Zanchenko Fonseca; Stephanie Santin; Luiz Guilherme Lisboa Gomes; Jaques Waisberg; Marcelo Augusto Fontenelle Ribeiro
Journal:  World J Hepatol       Date:  2014-03-27

Review 7.  Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic.

Authors:  Siobhán McGrane; Sean E McSweeney; Michael M Maher
Journal:  Abdom Imaging       Date:  2008 Jan-Feb

8.  Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy.

Authors:  Sang Won Kim; Hyunchul Rhim; Mihyun Park; Heejung Kim; Young-sun Kim; Dongil Choi; Hyo K Lim
Journal:  Korean J Radiol       Date:  2009-06-25       Impact factor: 3.500

9.  Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients.

Authors:  Hiroshi Kasugai; Yukio Osaki; Hiroko Oka; Masatoshi Kudo; Toshihito Seki
Journal:  Oncology       Date:  2007-12-13       Impact factor: 2.935

10.  Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.

Authors:  Sree Harsha Tirumani; Pamela Deaver; Atul B Shinagare; Harika Tirumani; Jason L Hornick; Suzanne George; Nikhil H Ramaiya
Journal:  J Gynecol Oncol       Date:  2014-08-05       Impact factor: 4.401

View more
  1 in total

Review 1.  Local treatment of oligometastatic disease: current role.

Authors:  Moritz T Winkelmann; Stephan Clasen; Philippe L Pereira; Rüdiger Hoffmann
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.